Benin Management Corp Bristol Myers Squibb CO Transaction History

Benin Management Corp

$354 Million
Q3 2024

A detailed history of Benin Management Corp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Benin Management Corp holds 7,942 shares of BMY stock, worth $440,383. This represents 0.12% of its overall portfolio holdings.

Number of Shares

7,942

Previous 7,952 0.13%

Holding current value

$440,383

Previous $330,000 24.24%

% of portfolio

0.12%

Previous 0.1%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$39.66 - $51.75 $396 - $517	-10 Reduced 0.13%	7,942 $410,000
Q2 2024 Jul 23, 2024	SELL	$40.25 - $52.99 $1,851 - $2,437	-46 Reduced 0.58%	7,952 $330,000
Q1 2024 Apr 15, 2024	SELL	$47.98 - $54.4 $20,007 - $22,684	-417 Reduced 4.96%	7,998 $433,000
Q4 2023 Jan 25, 2024	SELL	$48.48 - $57.85 $83,191 - $99,270	-1,716 Reduced 16.94%	8,415 $431,000
Q2 2023 Jul 24, 2023	SELL	$63.71 - $70.74 $14,079 - $15,633	-221 Reduced 2.13%	10,131 $647,000
Q4 2022 Feb 27, 2023	SELL	$68.48 - $81.09 $8,696 - $10,298	-127 Reduced 1.21%	10,352 $744,000
Q3 2022 Oct 21, 2022	SELL	$0.13 - $76.84 $3 - $1,921	-25 Reduced 0.24%	10,479 $745,000
Q2 2022 Aug 03, 2022	SELL	$72.62 - $79.98 $363 - $399	-5 Reduced 0.05%	10,504 $809,000
Q4 2021 Jan 19, 2022	BUY	$53.63 - $62.52 $16,089 - $18,756	300 Added 2.94%	10,509 $655,000
Q3 2021 Oct 25, 2021	SELL	$59.17 - $69.31 $23,668 - $27,724	-400 Reduced 3.77%	10,209 $604,000
Q2 2021 Jul 21, 2021	BUY	$61.91 - $67.42 $50,828 - $55,351	821 Added 8.39%	10,609 $709,000
Q1 2021 Apr 27, 2021	SELL	$59.34 - $66.74 $5,934 - $6,673	-100 Reduced 1.01%	9,788 $618,000
Q4 2020 Jan 25, 2021	SELL	$57.74 - $65.43 $11,548 - $13,086	-200 Reduced 1.98%	9,888 $613,000
Q3 2020 Oct 22, 2020	SELL	$57.43 - $63.64 $8,327 - $9,227	-145 Reduced 1.42%	10,088 $608,000
Q2 2020 Jul 22, 2020	SELL	$54.82 - $64.09 $3,289 - $3,845	-60 Reduced 0.58%	10,233 $602,000
Q1 2020 Apr 20, 2020	SELL	$46.4 - $67.43 $73,080 - $106,202	-1,575 Reduced 13.27%	10,293 $574,000
Q4 2019 Jan 23, 2020	BUY	$49.21 - $64.19 $152,551 - $198,989	3,100 Added 35.36%	11,868 $762,000
Q3 2019 Oct 22, 2019	SELL	$42.77 - $50.71 $5,346 - $6,338	-125 Reduced 1.41%	8,768 $445,000
Q2 2019 Jul 31, 2019	SELL	$44.62 - $49.34 $4,462 - $4,934	-100 Reduced 1.11%	8,893 $403,000
Q1 2019 Apr 24, 2019	SELL	$45.12 - $53.8 $58,791 - $70,101	-1,303 Reduced 12.66%	8,993 $429,000
Q4 2018 Jan 22, 2019	BUY	$48.76 - $63.23 $93,716 - $121,528	1,922 Added 22.95%	10,296 $535,000
Q3 2018 Oct 17, 2018	SELL	$55.19 - $62.25 $67,166 - $75,758	-1,217 Reduced 12.69%	8,374 $520,000
Q2 2018 Jul 20, 2018	BUY	$50.53 - $62.98 $141,585 - $176,469	2,802 Added 41.27%	9,591 $531,000
Q1 2018 Apr 24, 2018	SELL	$59.92 - $68.98 $39,906 - $45,940	-666 Reduced 8.93%	6,789 $429,000
Q4 2017 Jan 18, 2018	BUY	$59.94 - $65.35 $59 - $65	1 Added 0.01%	7,455 $457,000
Q3 2017 Oct 13, 2017	BUY	$55.23 - $63.74 $411,684 - $475,117	7,454	7,454 $475,000

Others Institutions Holding BMY

# of Institutions

2,453

Shares Held

1.5B

Call Options Held

29.6M

Put Options Held

32.1M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $118B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Benin Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Benin Management Corp with notifications on news.

Account

Benin Management Corp Bristol Myers Squibb CO Transaction History